New pages
- 15:34, 25 July 2021 Ciltacabtagene autoleucel (JNJ-68284528) (hist) [2,015 bytes] Jwarner (talk | contribs) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciltacabtagene-autoleucel NCI Drug Dictionary]: A preparation of autologous...")
- 19:25, 16 July 2021 Belumosudil (Rezurock) (hist) [698 bytes] Jwarner (talk | contribs) (new FDA approval)
- 22:53, 13 July 2021 Realgar-Indigo naturalis formula (hist) [950 bytes] Jwarner (talk | contribs) (Created page with "==Mechanism of action== From the NCI Drug Dictionary: An orally bioavailable, traditional Chinese medicine (TCM)-based formulation composed of Realgar-Indigo naturalis formula...")
- 21:37, 9 July 2021 Anaplastic large cell lymphoma, pediatric (hist) [10,026 bytes] Jwarner (talk | contribs) (Created page with "{| class="wikitable" style="text-align:center; width:50%;" !colspan="2" align="center" style="color:white; font-size:125%; background-color:#4a1486"|'''Section editor''' |- |s...")
- 08:09, 3 July 2021 Asparaginase erwinia chrysanthemi-rywn (Rylaze) (hist) [2,046 bytes] Jwarner (talk | contribs) (Created page with "'''Note: this is a recombinant product which is for all purposes identical to Asparaginase Erwinia chrysanthemi (Erwinaze). It is not a biosimilar.''' ==General informatio...")
- 08:39, 30 June 2021 Mantle cell lymphoma - historical (hist) [23,353 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to regimens that are obsolete, outdated, or of historical interest only. As a general rule, this includes the inferior arm(s)...")
- 09:51, 6 June 2021 Soft tissue sarcoma - null regimens (hist) [10,899 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to "null therapy" such as placebo and observation. While not clinically relevant, these references provide further insight in...")
- 14:27, 5 June 2021 Tislelizumab (BGB-A317) (hist) [1,032 bytes] Jwarner (talk | contribs) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/tislelizumab NCI Drug Dictionary]: A monoclonal antibody directed against th...")
- 11:50, 5 June 2021 Colon cancer, MSI-H or dMMR (hist) [22,795 bytes] Jwarner (talk | contribs) (Created page with "{| class="wikitable" style="text-align:center; width:100%;" ! colspan="2" align="center" style="color:white; font-size:125%; background-color:#08519c" |'''Page editor''' ! col...")
- 16:57, 4 June 2021 Dalpiciclib (SHR6390) (hist) [838 bytes] Jwarner (talk | contribs) (Created page with "==Mechanism of action== From [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/dalpiciclib NCI Drug Dictionary]: A cyclin-dependent kinase (CDK) inhibitor with...")
- 11:55, 4 June 2021 Toripalimab (JS001) (hist) [1,069 bytes] Jwarner (talk | contribs) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/toripalimab NCI Drug Dictionary]: A humanized immunoglobulin (Ig) G4 monoclo...")
- 16:36, 21 May 2021 Amivantamab (Rybrevant) (hist) [2,433 bytes] Jwarner (talk | contribs) (Created page with "==General information== Class/mechanism from the NCI Drug Dictionary: A human bispecific antibody targeting both epidermal growth factor receptor EGFR and hepatocyte growth fa...")
- 20:54, 19 May 2021 Low-grade glioma, pediatric (hist) [9,403 bytes] Jwarner (talk | contribs) (Created page with "{| class="wikitable" style="text-align:center; width:50%;" ! colspan="2" align="center" style="color:white; font-size:125%; background-color:#08519c" |'''Section editor''' |-...")
- 16:43, 14 May 2021 Iptacopan (LNP023) (hist) [1,471 bytes] Karine (talk | contribs) (Iptacopan drug index info)
- 10:33, 11 May 2021 Pancreatic cancer - historical (hist) [6,325 bytes] Jwarner (talk | contribs) (Created page with "The purpose of this page is to provide references to regimens that are obsolete, outdated, or of historical interest only. As a general rule, this includes the inferior arm(s)...")
- 22:13, 7 May 2021 High-grade glioma, pediatric (hist) [6,310 bytes] Jwarner (talk | contribs) (Created page with "{| class="wikitable" style="text-align:center; width:50%;" ! colspan="2" align="center" style="color:white; font-size:125%; background-color:#08519c" |'''Section editor''' |-...")
- 22:12, 7 May 2021 G207 (hist) [1,833 bytes] Jwarner (talk | contribs) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/oncolytic-hsv-1-g207 NCI Drug Dictionary]: A neuroattenuated, replication-co...")
- 14:43, 2 May 2021 Prostate cancer, BRCA-mutated (hist) [2,586 bytes] Jwarner (talk | contribs) (Created page with "{| class="wikitable" style="text-align:center; width:100%;" ! colspan="2" style="color:white; font-size:125%; background-color:#08519c" align="center" |'''Page editor''' ! col...")
